A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma
Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease that requires precise diagnosis for effective treatment. However, the diagnostic value of carbohydrate antigen 19 − 9 (CA19-9) is limited. Therefore, this study aims to identify novel tumor-associated autoantibodies...
Salvato in:
| Autori principali: | , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2023-11-01
|
| Serie: | Cancer Cell International |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1186/s12935-023-03107-1 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|